Anti-endothelial cell antibodies and antiphospholipid antibodies in Takayasu's arteritis: Correlations of their titers and isotype distributions with disease activity

Clinical and Experimental Rheumatology

Volumn 24, Issue 2 SUPPL. 41, 2006, Pages

  Park, Min Chan ^a   Park, Yong Beom ^a   Jung, Sang Youn ^a   Lee, Kwang Hoon ^a   Lee, Soo Kon ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Anti endothelial cell antibodies; Antiphospholipid antibodies; Disease activity; Takayasu's arteritis

Indexed keywords

ENDOTHELIAL CELL ANTIBODY; IMMUNOGLOBULIN CLASS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PHOSPHOLIPID ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; AORTA ARCH SYNDROME; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PREVALENCE; PRIORITY JOURNAL; UMBILICAL VEIN;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; AUTOANTIBODIES; BLOOD SEDIMENTATION; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; TAKAYASU'S ARTERITIS; UMBILICAL VEINS;

EID: 33745684337     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. KERR GS, HALLAHAN CW, GIORDANO J et al.: Takayasu arteritis. Ann Intern Med 1994; 120: 919-29.
2. LONG A, BRUNEVAL P, LAURIAN C, CORMIER JM, CAMILLERI JP, FIESSINGER JN: Takayasu's disease: diagnostic and therapeutic value of subclavian artery biopsy. Ann Vasc Surg 1990; 4: 151-5.
3. SEKO Y: Takayasu's arteritis: Insights into immunopathology. Jpn Heart J 2000; 41: 15-26.
4. WEYAND CM, GORONZY JJ: Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis. Curr Opin Rheumatol 1995; 7: 30-6.
5. IGARASH T, NAGAOKA S, MATSUNAGA K: Aortitis syndrome associated with systemic lupus erythematosus. J Rheumatol 1989; 16: 1579-85.
6. WILSON WA, MORGAN OS, BAIN B: Takayasu's arteritis: association with Still's disease in an adult. Arthritis Rheum 1979; 22: 684-90.
7. FRAGA A, MINTZ G, VALLE L, FLORES-IZQUIERDO G: Takayasu's arteritis: frequency of systemic manifestations (study of 22 patients) and favorable response to maintenance steroid therapy with adrenocorticosteroids (12 patients). Arthritis Rheum 1972; 15: 617-24.
8. HOFFMAN GS, LEAVITT RY, KERR GS, ROTTEM M, SNELLER MC, FAUCI AS: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum 1994; 37: 578-82.
9. FERRANO G, MERONI PL, TINCANI A et al.: Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79: 47-53.
10. MULLER KOBOLD AC, VAN WIJK RT, FRANSSEN CF, MOLEMA G, KALLENNBERG CG, TERVAERT JW: In vitro up-regulation of E-selectin and induction of interleukin-6 in endothelial cells by autoantibodies in Wegener's granulomatosis and microscopic polyangiitis. Clin Exp Rheumatol 1999; 17: 433-40.
11. HOLMEN C, CHRISTENSSEN M, PETTERSSON E et al.: Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies. Kidney Int 2004; 66: 1049-60.
12. GOBELL U, EICHHORN J, KETTRITZ R et al.: Disease activity and autoantibodies to endothelial cells in patients with Wegener's granulomatosis. Am J Kidney Dis 1996; 28: 186-94.
13. GRUNEBAUM E, BLANK M, COHEN S et al.: The role of anti-endothelial cell antibodies in Kawasaki disease: in vitro and in vivo studies. Clin Exp Immunol 2002; 130: 233-40.
14. LEUNG DY, COLLINS T, LAPIERRE LA, GEHA RS, POBER JS: Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986; 77: 1428-35.
15. LEE KH, CHUNG HS, KIM HS et al.: Human α-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease. Arthritis Rheum 2003; 48: 2025-35.
16. SONG J, PARK YB, LEE WK, LEE KH, LEE SK: Clinical associations of anti-endothelial cell antibodies in patients with systemic lupus erythematosus. Rheumatol Int 2000; 20: 1-7.
17. NAVARRO M, CERVERA R, FONT J et al.: Anti-endothelial cell antibodies in systemic autoimmune diseases: prevalence and clinical significance. Lupus 1997; 6: 521-6.
18. CARVALHO D, SAVAGE CO, ISENBERG D, PEARSON JD: IgG anti-endothelial cell autoantibodies from patients with systemic lupus erythematosus or systemic vasculitis stimulate the release of two endothelial cell-derived mediators, which enhance adhesion molecule expression and leukocyte adhesion in an autocrine manner. Arthritis Rheum 1999; 42: 631-40.
19. DEL PAPA N, GUIDALI L, SIRONI M et al.: Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39: 758-66.
20. BORDRON A, DUEYMES M, LEVY Y et al.: The binding of some human anti-endothelial cell antibodies induces endothelial cell apoptosis. J Clin Invest 1998; 101: 2029-35.
21. DAMIANOVICH M, GILBURD B, GEORGE J et al.: Pathogenic role of anti-endothelial cell antibodies in vasculitis. An idiotypic experimental model. J Immunol 1996; 156: 4946-51.
22. NITYANAND S, MISHRA K, SHRIVASTAVA S, HOLM G, LEFVERT AK: Autoantibodies against cardiolipin and endothelial cells in Takayasu's arteritis: Prevalence and isotype distribution. Br J Rheumatol 1997; 36: 923-4.
23. SIMA D, THIELE B, TUROWSKI A et al.: Anti-endothelial antibodies in Takayasu's arteritis. Arthritis Rheum 1994; 37: 441-3.
24. EICHHORN J, SIMA D, THIELE B et al.: Anti-endothelial cell antibodies in Takayasu's arteritis. Circulation 1996; 94: 2396-401.
25. BLANK M, KRAUSE I, GOLDKORN T et al.: Monoclonal anti-endothelial cell antibodies from a patient with Takayasu's arteritis activate endothelial cells from large vessels. Arthritis Rheum 1999; 42: 1421-32.
26. CHAKRAVARTY K, POUNTAIN G, MERRY P, BYRON M, HAZLEMAN B, SCOTT DGI: A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis. J Rheumatol 1995; 22: 1694-7.
27. HANSEN KE, MOORE KD, ORTEL TL, ALLEN NB: Antiphospholipid antibodies in patients with Wegener's granulomatosis and polyarteritis nodosa. Arthritis Rheum 1999; 42: 2251-5.
28. PIERANGELI SS, COLDEN-STANFIELD M, LIU X, BARKER JH, ANDERSON GL, HARRIS EN: Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 1999; 99: 1997-2002.
29. DEL PAPA N, GUIDALI L, SALA A et al.: Endothelial cells as target for antiphospholipid antibodies. Arthritis Rheum 1997; 40: 551-61.
30. MISRA R, AGGARWAL A, CHAG M, SINHA N, SHRIVASTAVA S: Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet 1994; 343: 1644-5.
31. NAVA A, LUC SENECAL JL, BANALES JL, RAYMOND I, REYES PA: Absence of antiphospholipid / co-factor antibodies in Takayasu's arteritis. Int J Cardiol 2000; 75 (Suppl. 1): S99-104.
32. AREND WP, MICHEL BA, BLOCH DA et al.: The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis Rheum 1990; 33: 1129-34.
33. EXNER T, TRIPLETT DA, TABERNER D, MACHIN SJ: The guidelines for testing and revised criteria for lupus anticoagulants. Thromb Haemostas 1991; 65: 320-2.
34. SHEIKHZADEH A, TETTENBORN I, NOOHI F, EFTEKHARZADEH M, SCHNABEL A: Occlusive thromboaortopathy (Takayasu's disease): clinical and angiographic features and a brief review of literature. Angiology 2002; 53: 29-40.
35. KANZAKI S, KANDA S: Coombs' antibodies and rheumatoid factors in Takayasu's arteritis. JAMA 1985; 254: 232.
36. TRIPATHY NK, UPADHYAYA S, SINHA N, NITYANAND S: Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001; 28: 805-8.
37. HILL MB, PHIPPS JL, CARTWRIGHT RJ, MILFORD-WARD A, GREAVES M, HUGHES P: Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996; 106: 491-7.
38. HILL MB, PHIPPS JL, MILFORD-WARD A, GREAVES M, HUGHES P: Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996; 35: 1231-8.
39. TRIPATHY NK, SINHA N, NITYANAND S: Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 2003; 134: 360-4.
40. PRAPROTNIK S, BLANK M, MERONI PL, ROZMAN B, ELDOR A, SHOENFELD Y: Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: The pathogenic and diagnostic implications. Arthritis Rheum 2001; 44: 1484-94
41. SUBRAMANYAN R, JOY J, BALAKRSHNAN KG: Natural history of aortoarteritis (Takayasu's disease). Circulation 1989; 80: 429-37.
42. ISHIKAWA K: Natural history and classification of occlusive thromboangiopathy (Takayasu's disease). Circulation 1978; 57: 27-35.
43. ISHIKAWA K, MAETANI S: Long-term outcome for 120 Japanese patients with Takayasu's disease. Clinical and statistical analyses of related prognostic factors. Circulation 1994; 90: 1855-60.
44. YOKOI K, HOSOI E, AKAIKE M, SHIGEKIYO T, SAITO S: Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology 1996; 47: 315-9.
45. FILER A, NICHOLLS D, CORSTON R, CAREY P, BACON P: Takayasu arteritis and atherosclerosis: illustrating the consequences of endothelial damage. J Rheumatol 2001; 28: 2752-3.